Is there a vaccine against RSV? After nearly 60 years, many potential candidates came at the same time

Published Date: 02 Mar 2023

You may not have heard of respiratory syncytial virus (RSV). However, it killed more than 100,000 people worldwide in 2019, making it the leading cause of death among children under the age of one.

Read Full News

Latest News

Burden of ED Urologic Care Increases in Ontario

Emergency department visits and admissions for urology conditions surged in Ontario from 2007 to 2022, with longer wait times, especially for women and patients with low income.

Cost-Related Delay in Care Tied to Higher ED Use

Delaying or forgoing care for cost-related reasons is linked to increased odds of emergency department visits among Latino adults, highlighting the need to reduce financial barriers to timely care.

Physician Attire and Trust: How Much Does It Matter?

Physicians’ clothing influences how patients judge competence and approachability, with preferences varying by care setting and specialty and shaping clinical interactions.

‘Dancing’ Molecules Spur Healing in Spinal Cord Tissue

Researchers created a human spinal cord organoid, injured it, then applied an experimental therapy. What happened next was surprising and illuminating.

First AAD Guidelines Issued for Pediatric Eczema

For the first time, the American Academy of Dermatology has issued treatment guidelines specific for the control of atopic dermatitis in children.

Researchers Eye Potential Down Syndrome Fix Via Advanced Gene Editing

Researchers have developed a modified version of the CRISPR gene-editing tool that in early laboratory experiments suggests it may have the potential to “silence” the extra...

Todays Updates

Is Vitamin D a Key to Better Breast Cancer Survival?

A prospective study links sufficient vitamin D levels at the time of breast cancer diagnosis to improved overall survival.

Todays Updates

Is Vitamin D a Key to Better Breast Cancer Survival?

A prospective study links sufficient vitamin D levels at the time of breast cancer diagnosis to improved overall survival.

Latest News

Emergency department visits and admissions for urology conditions surged in Ontario from 2007 to 2022, with longer wait times, especially for women and patients with low income.

Delaying or forgoing care for cost-related reasons is linked to increased odds of emergency department visits among Latino adults, highlighting the need to reduce financial barriers to timely care.

Physicians’ clothing influences how patients judge competence and approachability, with preferences varying by care setting and specialty and shaping clinical interactions.

Researchers created a human spinal cord organoid, injured it, then applied an experimental therapy. What happened next was surprising and illuminating.

For the first time, the American Academy of Dermatology has issued treatment guidelines specific for the control of atopic dermatitis in children.

Researchers have developed a modified version of the CRISPR gene-editing tool that in early laboratory experiments suggests it may have the potential to “silence” the extra...

News All Time

Study Identifies Novel Stress-Inflammation Pathway in AD

Most patients and doctors know that stress exacerbates AD. A new study pinpoints a neural mechanism that may be involved in this process.

Scotland Backs New Immunotherapy in Advanced Cervical Cancer

The Scottish Medicines Consortium has accepted pembrolizumab with chemoradiotherapy for high-risk, locally advanced cervical cancer in Scotland.

Eye Shingles Tied to Cancer Risk in Those With Immune Issues

Herpes zoster ophthalmicus is associated with an increased risk for subsequent malignancy among individuals with an underlying history of immune dysregulation, according to a recent cohort study.

SLIT Adherence May Lower Rhinitis Severity in Children

Higher adherence to sublingual pollen immunotherapy in children with allergic rhinitis is linked to lower odds of severe rhinitis.

Novo Nordisk Weight-loss Drug Shows Liver Benefits in Mouse Study

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)

Schistosomiasis: Four Things You May Not Know

From Ancient Egypt to Modern China, how parasitic worms have shaped human health and world history.

C auris Is Now Endemic in Europe. Can It Be Contained?

The fungus, identified only 20 years ago, is endemic in healthcare facilities of five European countries. What can be done to stop its spread?

New Pulmonary Embolism Clinical Categories PCPs Should Know

Dr Nina Lum discusses key takeaways of new PE clinical categories for primary care physicians and providers.

Amgen's Lung Cancer Drug Tarlatamab Wins China Approval

Amgen's lung cancer drug tarlatamab has won ⁠approval from China's National Medical Products Administration.

Preparing for the Next Pandemic: What the EU Wants

The EU aims to offer pharmaceutical companies ‘workable terms’ in policies designed to improve future pandemic response.

EPP and XLP: Dersimelagon Delays Photodermatoses Prodrome

A dermatologist with erythropoietic protoporphyria herself presents results of the INSPIRE randomized controlled trial of dersimelagon.

US FDA Expands Approval for Travere's Drug for Rare Kidney Disease

The U.S. Food and Drug Administration has approved the expanded use of Travere Therapeutics' ⁠drug to treat a rare kidney disorder, the company said on Monday.

Pemphigus: Rituximab Shows Lower Cancer Risk Than Other Txs

Rituximab is linked to a lower 5-year risk for new cancer than mycophenolate mofetil or azathioprine in patients with pemphigus, study shows.

Gastritis Study Reveals Antibody-Anemia Connection

Anemia is common in patients with autoimmune gastritis and is associated with positivity for anti-intrinsic factor antibodies.

Nemolizumab Findings Positive for Younger Kids With AD

Already FDA-approved for adults and children 12 years or older, researchers explore extending the nemolizumab age range down to 2 years in atopic dermatitis.

Systemic Onychomycosis Rxs: Hepatoxicity Risks Compared

Terbinafine shows lower risk for hepatotoxicity than other systemic antifungal treatments in patients with onychomycosis and chronic liver disease.

Recommended News For You

Cancer tumor anatomy influences the benefits of chemotherapy for patients with early-stage breast cancer.

Scholastic performance is a key concern for young cancer patients, study finds

Promising Results With Epcoritamab Monotherapy in Relapsed/Refractory CLL

In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.

Prostate cancer death risk is higher in late teens and early 20s weight gain.

According to research, hospitals can save money and help cancer patients by implementing a basic intervention.

Children living near oil and gas wells face higher risk of rare leukemia, studies show

Recommended Articles For You

The Latest Research on Acute Promyelocytic Leukemia: Advancements in Diagnosis and Therapy  

Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma 

The Latest Research on Wiskott Aldrich Syndrome  

The Pros and Cons of Using Cyclophosphamide in Cancer Treatment  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.

2.

Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer

3.

Radiation from CT scans could account for 5% of all cancer cases a year, study suggests

4.

According to a study, taking part in a clinical trial for cancer may not actually increase survival.

5.

Weight-Based and Fixed-Dose Pembrolizumab Compared in NSCLC

1.

Exploring the Latest Advances in Hodgkin's Lymphoma Treatment

2.

The Mysterious Pain of Scrotal Hematoma: A Guide to Diagnosis and Treatment

3.

Claudin-18.2 in Gastric Cancer: Tumor-Stroma Crosstalk and Disease Progression

4.

Precision Oncology: Cancer Screening, Genetic Counseling & Hereditary Cancer Syndromes Integration

5.

Breakthroughs in Oncology: Advances in Immunotherapy, Radiation & Precision Diagnostics

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

First Line Combination Therapy- The Overall Survival Data in NSCLC Patients

2.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I

3.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II

4.

Current Scenario of Cancer- Palliative Care to Close the Care Gap

5.

Navigating the Complexities of Ph Negative ALL - Part X

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot